| Page 1715 | Kisaco Research
 

Iman Farasat

Associate Director, Biologics Discovery
The Janssen Pharmaceutical Companies of Johnson & Johnson

Iman Farasat

Associate Director, Biologics Discovery
The Janssen Pharmaceutical Companies of Johnson & Johnson

Iman Farasat

Associate Director, Biologics Discovery
The Janssen Pharmaceutical Companies of Johnson & Johnson
 

Nikolaos A. Katerelos

Scientific Officer
Hellenic Food Authority (EFET)

Nikolaos A. Katerelos

Scientific Officer
Hellenic Food Authority (EFET)

Nikolaos A. Katerelos

Scientific Officer
Hellenic Food Authority (EFET)
 

Prof. Dr. Reinhard Sterner

Institute for Biophysics and Physical Biochemistry
University of Regensburg

Prof. Dr. Reinhard Sterner

Institute for Biophysics and Physical Biochemistry
University of Regensburg

Prof. Dr. Reinhard Sterner

Institute for Biophysics and Physical Biochemistry
University of Regensburg
 

Per-Olof Syrén

Associate Professor in Chemistry, Department of Fiber and Polymer Technology
KTH Royal Institute of Technology

Per-Olof Syrén

Associate Professor in Chemistry, Department of Fiber and Polymer Technology
KTH Royal Institute of Technology

Per-Olof Syrén

Associate Professor in Chemistry, Department of Fiber and Polymer Technology
KTH Royal Institute of Technology
 

Mehdi D. Davari

Head of Computational Biology Division, Institute of Biotechnology
RWTH Aachen University

Mehdi D. Davari

Head of Computational Biology Division, Institute of Biotechnology
RWTH Aachen University

Mehdi D. Davari

Head of Computational Biology Division, Institute of Biotechnology
RWTH Aachen University
 

Christophe Ullmann

Project Manager
Protéus by Seqens

Christophe Ullmann

Project Manager
Protéus by Seqens

Christophe Ullmann

Project Manager
Protéus by Seqens
 

Pierre Gilles

Project Manager
Protéus by Seqens

Pierre Gilles

Project Manager
Protéus by Seqens

Pierre Gilles

Project Manager
Protéus by Seqens
 

Murray Brown

Global Coordinator, Synthetic Biology
GlaxoSmithKline

Murray Brown

Global Coordinator, Synthetic Biology
GlaxoSmithKline

Murray Brown

Global Coordinator, Synthetic Biology
GlaxoSmithKline
 

Jon Congdon

President & Co-founder
Beachbody

As CEO, Jon is responsible for driving the vision and growth for Openfit, the all-in-one digital streaming platform for integrated fitness, nutrition and wellness that launched in 2019.  Under his leadership, Openfit has expanded its offerings for subscribers, including the addition of live classes, personalized meal-prep and nutrition tracking tools, and grown the subscriber base by 3.5X YTD 2020.

 

As President of Beachbody, he is responsible for all Direct to Consumer Marketing, Media, Strategic Analysis and Insights, and Human Resources (The People Department).

Jon Congdon

President & Co-founder
Beachbody

Jon Congdon

President & Co-founder
Beachbody

As CEO, Jon is responsible for driving the vision and growth for Openfit, the all-in-one digital streaming platform for integrated fitness, nutrition and wellness that launched in 2019.  Under his leadership, Openfit has expanded its offerings for subscribers, including the addition of live classes, personalized meal-prep and nutrition tracking tools, and grown the subscriber base by 3.5X YTD 2020.

 

As President of Beachbody, he is responsible for all Direct to Consumer Marketing, Media, Strategic Analysis and Insights, and Human Resources (The People Department).

A former ranked beach volleyball player and functional fitness and yoga practitioner, Congdon has long been an advocate for health and well-being, with a balanced approach to fitness, wellness and nutrition. He serves on the St. John’s Health Center Foundation’s Board of Trustees, and is a founding Board Member of the Careyes Foundation, addressing youth education and community issues in the Costa Allegre region in Jalisco, Mexico.

 

Congdon graduated from the University of California, Los Angeles (UCLA).  He lives in Malibu, California, with his wife Becca and daughter Gigi.